Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B PatientsCompleted
NCT01373684Phase 4Updated Nov 8, 2019
Sponsor: Foundation for Liver Research
Chronic Hepatitis B
Canada, Netherlands
Tocilizumab REMission in Early RACompleted
NCT04157010Phase 4Updated Nov 8, 2019
Sponsor: University of Leeds
Rheumatoid Arthritis
United Kingdom
A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy VolunteersCompleted
NCT03586726Phase 1Updated Nov 7, 2019
Sponsor: Hoffmann-La Roche
Healthy Volunteers
Netherlands
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and HematologyCompleted
NCT01660776N/AUpdated Nov 6, 2019
Sponsor: Rennes University Hospital
Diffuse Large B-cell Lymphoma · Hodgkin Lymphoma · Metastatic Breastcancer · Non-small Cell Lung Cancer
France
A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)Completed
NCT01455701Phase 1Updated Nov 4, 2019
Sponsor: Hoffmann-La Roche
Juvenile Idiopathic Arthritis
United States, Argentina, Belgium, Canada, Germany +3 more
A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy VolunteersCompleted
NCT03579719Phase 1Updated Nov 4, 2019
Sponsor: Hoffmann-La Roche
Healthy Volunteers
Netherlands
Study to Compare the Efficacy of Tocilizumab With or Without Glucocorticoid Discontinuation in Rheumatoid Arthritis ParticipantsCompleted
NCT02573012Phase 4Updated Nov 1, 2019
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
France, Germany, Italy, Russia, Serbia +1 more
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and CrizotinibCompleted
NCT02604342Phase 3Updated Oct 29, 2019
Sponsor: Hoffmann-La Roche
Non-small Cell Lung Cancer
Belgium, Bulgaria, France, Germany, Hong Kong +10 more
Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast CancerCompleted
NCT02445586Phase 4Updated Oct 29, 2019
Sponsor: Hoffmann-La Roche
Breast Cancer
India
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic LeukemiaCompleted
NCT01905943Phase 3Updated Oct 28, 2019
Sponsor: Hoffmann-La Roche
Chronic Lymphocytic Leukemia
Argentina, Belgium, Bosnia and Herzegovina, Brazil, Canada +26 more
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.Completed
NCT00643565Phase 2Updated Oct 22, 2019
Sponsor: Hoffmann-La Roche
Sarcoma
Belgium, Brazil, Canada, Chile, Czechia +9 more
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationTerminated
NCT02247531Phase 3Updated Oct 15, 2019
Sponsor: Hoffmann-La Roche
Geographic Atrophy
United States, Argentina, Australia, Austria, Belgium +17 more
A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerCompleted
NCT01748773Phase 2Updated Oct 9, 2019
Sponsor: Hoffmann-La Roche
Gastric Cancer · Gastroesophageal Junction Cancer
Turkey (Türkiye)
An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)Completed
NCT01697488N/AUpdated Oct 8, 2019
Sponsor: Hoffmann-La Roche
Peritoneal Neoplasms
Germany
Bevacizumab And Combination Chemotherapy in Rectal Cancer Until SurgeryCompleted
NCT01650428Phase 2Updated Oct 7, 2019
Sponsor: University College, London
Rectal Cancer
United Kingdom
A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"Completed
NCT01903993Phase 2Updated Oct 2, 2019
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, Belgium, Canada, France, Germany +8 more
A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Emicizumab in Healthy Chinese VolunteersCompleted
NCT03380780Phase 1Updated Sep 30, 2019
Sponsor: Hoffmann-La Roche
Healthy Volunteers · Hemophilia A
China
Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513Completed
NCT03507569Phase 1Updated Sep 30, 2019
Sponsor: Hoffmann-La Roche
Autism Spectrum Disorder
United Kingdom
Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway InhibitorCompleted
NCT02814669Phase 1Updated Sep 24, 2019
Sponsor: Hoffmann-La Roche
Castrate-Resistant Prostate Cancer
United States
Study of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Participants With Early/Metastatic Breast Cancer in Saudi ArabiaCompleted
NCT02954471N/AUpdated Sep 20, 2019
Sponsor: Hoffmann-La Roche
Breast Cancer
Saudi Arabia
A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)Completed
NCT01926886Phase 3Updated Sep 18, 2019
Sponsor: Hoffmann-La Roche
Breast Cancer
Belgium, Israel
Study of the Relative Oral Bioavailability of the Antiflu Medicine Oseltamivir in the Intensive Care UnitWithdrawn
NCT00844155NAUpdated Sep 17, 2019
Sponsor: University of Manitoba
Influenza A Virus Infection · Influenza B Virus Infection
Canada
Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential ThrombocythemiaCompleted
NCT02407080Phase 1Updated Sep 12, 2019
Sponsor: John Mascarenhas
Polycythemia Vera · Essential Thrombocythemia
United States
Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast CancerCompleted
NCT02402712Phase 3Updated Sep 6, 2019
Sponsor: Hoffmann-La Roche
Breast Cancer
Belgium, Bulgaria, Canada, France, Germany +7 more
A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaCompleted
NCT02453087Phase 1Updated Aug 29, 2019
Sponsor: Hoffmann-La Roche
Non-Hodgkin's Lymphoma
United States

Previous page Next page